[LIPO] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[LIPO] Lipella Pharmaceuticals Inc.
Announcement Date
12-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- 2,894.77%
YoY- 1,474.66%
Quarter Report
LIPO's Result
LIPO's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 121 104,051 106,676 118 151 0 0 -
PBT -689 -1,324 -1,539 -1,068 -364 -714 -782 -8.07%
Tax -58,388 33,124 36,477 -11,213 -1 -1 -1 147425.54%
NP -689 -1,324 -1,539 10,145 -363 -713 -781 -7.99%
Tax Rate - - - - - - - -
Total Cost 810 105,375 108,215 -10,027 514 713 781 2.45%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -570.07 -1.27 -1.44 8,594.11 -240.25 0.00 0.00 -
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -0.11 -0.23 -0.27 1.77 -0.06 -0.12 -0.14 -14.81%
EPS Diluted -0.11 -0.23 -0.27 1.77 -0.06 -0.12 -0.14 -14.81%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.